Abstract: The present invention relates to novel compositions of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel methods to select HIV infected patients with improved responses to HIV-specific vaccine peptides.
Type:
Grant
Filed:
January 27, 2015
Date of Patent:
December 4, 2018
Assignee:
BIONOR PHARMA ASA
Inventors:
Anker Lundemose, Mats Ökvist, Arnt Ove Hovden, Maja Sommerfelt Grønvold